Total Payments
$291,322
2024 Payments
$13.94
Companies
15
Transactions
501
Medicare Patients
3,948
Medicare Billing
$965,067
Payment Breakdown by Category
Other$226,266 (77.7%)
Travel$43,971 (15.1%)
Consulting$15,025 (5.2%)
Food & Beverage$5,934 (2.0%)
Education$126.32 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $225,466 | 80 | 77.4% |
| Travel and Lodging | $43,971 | 250 | 15.1% |
| Consulting Fee | $15,025 | 6 | 5.2% |
| Food and Beverage | $5,934 | 157 | 2.0% |
| Grant | $800.00 | 2 | 0.3% |
| Education | $126.32 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $121,016 | 218 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $69,732 | 121 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $45,102 | 61 | $0 (2022) |
| Relypsa, Inc. | $33,904 | 55 | $0 (2020) |
| Travere Therapeutics, Inc. | $6,303 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $5,839 | 17 | $0 (2023) |
| Calliditas Therapeutics US Inc. | $3,611 | 3 | $0 (2023) |
| Vifor Pharma, Inc. | $3,588 | 5 | $0 (2021) |
| ANI Pharmaceuticals, Inc. | $1,175 | 2 | $0 (2021) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $900.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.94 | 1 | Mallinckrodt Hospital Products Inc. ($13.94) |
| 2023 | $13,168 | 32 | Travere Therapeutics, Inc. ($6,300) |
| 2022 | $43,625 | 81 | Mallinckrodt Hospital Products Inc. ($26,598) |
| 2021 | $39,786 | 42 | Bayer HealthCare Pharmaceuticals Inc. ($31,700) |
| 2020 | $36,868 | 56 | Mallinckrodt Hospital Products Inc. ($34,065) |
| 2019 | $73,803 | 120 | Mallinckrodt Enterprises LLC ($59,532) |
| 2018 | $66,578 | 131 | Mallinckrodt LLC ($44,017) |
| 2017 | $17,480 | 38 | Mallinckrodt LLC ($17,466) |
All Payment Transactions
501 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 11/28/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $174.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $81.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $37.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $5.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,560.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $277.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $260.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $136.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $129.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.86 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $33.59 | General |
| 08/18/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 08/09/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/28/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2023 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $233.62 | General |
| 04/17/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $134.38 | General |
| 04/17/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $70.00 | General |
| 04/17/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $56.00 | General |
| 04/17/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 04/04/2023 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| 04/04/2023 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $90.65 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 917 | 2,005 | $417,929 | $201,253 |
| 2022 | 13 | 1,020 | 2,293 | $493,667 | $235,358 |
| 2021 | 12 | 962 | 2,282 | $526,756 | $257,736 |
| 2020 | 13 | 1,049 | 2,806 | $655,474 | $270,720 |
Total Patients
3,948
Total Services
9,386
Medicare Billing
$965,067
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 438 | 1,034 | $196,460 | $93,056 | 47.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 110 | 410 | $63,550 | $37,865 | 59.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 22 | 102 | $35,700 | $15,633 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $32,480 | $14,274 | 43.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 15 | 64 | $28,800 | $14,219 | 49.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 74 | 87 | $26,100 | $11,830 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 107 | $16,050 | $6,192 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 20 | $5,000 | $2,835 | 56.7% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 14 | 32 | $5,536 | $2,147 | 38.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,620 | $2,027 | 43.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 15 | 21 | $3,633 | $1,175 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 474 | 1,075 | $204,250 | $94,699 | 46.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 129 | 530 | $82,150 | $42,563 | 51.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 15 | 73 | $42,340 | $20,679 | 48.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 21 | 78 | $35,100 | $18,368 | 52.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 73 | 82 | $24,600 | $12,585 | 51.2% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 25 | 75 | $26,250 | $12,123 | 46.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 100 | 100 | $28,000 | $11,448 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 84 | $12,600 | $5,473 | 43.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 33 | $8,250 | $4,753 | 57.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $10,010 | $4,559 | 45.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 56 | $6,104 | $3,132 | 51.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 27 | 49 | $8,477 | $2,803 | 33.1% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 13 | 32 | $5,536 | $2,172 | 39.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 477 | 1,243 | $236,170 | $115,537 | 48.9% |
About Dr. Dmitri Vasin, MD
Dr. Dmitri Vasin, MD is a Nephrology healthcare provider based in Bremerton, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730132689.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dmitri Vasin, MD has received a total of $291,322 in payments from pharmaceutical and medical device companies, with $13.94 received in 2024. These payments were reported across 501 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($225,466).
As a Medicare-enrolled provider, Vasin has provided services to 3,948 Medicare beneficiaries, totaling 9,386 services with total Medicare billing of $965,067. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Bremerton, WA
- Active Since 05/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1730132689
Products in Payments
- ACTHAR (Biological) $190,713
- Kerendia (Drug) $45,082
- Veltassa (Drug) $37,460
- LOKELMA (Drug) $5,726
- TARPEYO (Drug) $3,611
- PURIFIED CORTROPHIN GEL (Drug) $1,175
- FARXIGA (Drug) $113.63
- SAMSCA (Drug) $61.20
- LUPKYNIS (Drug) $27.51
- AURYXIA (Drug) $27.06
- Auryxia (Drug) $22.10
- Rayaldee (Drug) $14.01
- (815) Thiola (Drug) $3.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.